In COVID-19 positive patients, as COVID-19 severity worsened from mild to fatal, the plasma GDF-15 levels increased with the highest median GDF-15 levels detected in the fatal group (p<0.0001) (Figure 1B). This evidence concerns the gene GDF15 and COVID-19.